🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lilian T. Gien

Sunnybrook Health Science Centre

ORCID: 0000-0002-6558-3337

Also affiliated with University of Toronto, Health Sciences Centre, Institute of Health Services and Policy Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “A randomized phase III, two-arm trial of paclitaxel, carboplatin, and maintenance letrozole versus letrozole monotherapy in patients with stage II-IV, primary low-grade serous carcinoma of the ovary or peritoneum.”.

A randomized phase III, two-arm trial of paclitaxel, carboplatin, and maintenance letrozole versus letrozole monotherapy in patients with stage II-IV, primary low-grade serous carcinoma of the ovary or peritoneum.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps5601
N/A
0DataRank · unranked
11 citations

Lilian T. Gien, Austin Miller, Al Covens, David M. Gershenson, Amanda N. Fader

Trial in progress: Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: Groningen International Study on Sentinel Nodes in Vulvar Cancer III (GROINSS-V III/NRG-GY024).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps5624
N/A
0DataRank · unranked
0 citations

Brian M. Slomovitz, Mario M. Leitão, Ate G.J. van der Zee, Carien L. Creutzberg, A.K.L. Reyners +6 more

Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.027
N/A
0DataRank · unranked
20 citations

Danielle Enserro, Matthew S. Block, Steven Waggoner, Linda Duska, Andrea E. Wahner-Hendrickson +11 more

Phase II Study of Sunitinib in Tumors With c-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V

JCO Precision Oncology(2024)10.1200/po-24-00514
N/A
0DataRank · unranked
0 citations

Zihe Song, Andrew Poklepovic, Eric A. Collisson, James A. Zwiebel, Robert J. Gray +14 more